• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE FEM NAR POR CR LT SZ 6; ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE FEM NAR POR CR LT SZ 6; ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL Back to Search Results
Model Number 1504-01-126
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Codes Inadequate Osseointegration (2646); No Code Available (3191)
Date of Event 10/29/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Primary attune total knee implanted due to osteoarthritis of the left knee.The patella was resurfaced, and depuy cement x 1 was utilized.There were no surgical or postoperative complications reported.Revision of the left knee due to loosening of the tibial tray.Intraoperatively, the surgeons found loosening of the tibial tray and femoral component at the implant to bone interface as evidenced by fibrous ingrowth and easy removal.The patellar component was well-fixed but revised.There was no reported product problem with the revised tibial insert.The procedure was completed without complications and the patient was revised with depuy components and depuy cement x2.Doi: (b)(6) 2018; dor: (b)(6) 2019; left knee.
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE FEM NAR POR CR LT SZ 6
Common Device Name
ATTUNE CEMENTLESS IMPLANTS : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key9739401
Report Number1818910-2020-05656
Device Sequence Number355445
Product Code JWH
UDI-Device Identifier10603295041436
UDI-Public10603295041436
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K140881
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2019
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1504-01-126
Device Catalogue Number150401126
Device Lot Number8512178
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/05/2020
Supplement Date Received by Manufacturer03/24/2020
Initial Report FDA Received Date02/21/2020
Supplement Report FDA Received Date03/27/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE CR RP INSRT SZ 6 8MM; ATTUNE FEM NAR POR CR LT SZ 6; ATTUNE MEDIAL DOME PAT 38MM; ATTUNE RP TIB BASE SZ 5 POR; DEPUY CMW 2 20G
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient Weight76
-
-